Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bartholomew International Investments is a private investment and holding company based in the United Kingdom, primarily serving as the investment vehicle for Dr. Geoffrey Guy, the founder of GW Pharmaceuticals. The firm specializes in strategic investments within the life sciences and biotechnology sectors, with a historical focus on UK-based innovation. It has held significant equity positions in prominent companies such as Oxford BioMedica, GW Pharmaceuticals, and Vectura. While the company does not develop its own therapeutic pipeline, it is a notable participant in the biotech ecosystem through its capital support of drug development and medical technology firms. The company's activities are closely aligned with the expertise of its principal in areas such as cannabinoid medicine and advanced therapeutic modalities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bartholomew International Investments.